Safety evaluation of Bacillus coagulans AO1167 for its use as a probiotic in humans |
07/08/2023 |
HHA |
Safety evaluation of Bacillus clausii AO1125 for its use as a probiotic in humans |
07/08/2023 |
HHA |
Safety and pharmacokinetics of CIGB-552 |
22/05/2015 |
CIGB |
Safety and immunogenicity of VCN7-T in infants of 2 and 3 months. Phase I/II. |
28/04/2017 |
FINLAY |
Safety and immunogenicity of the CIGB 2020. |
14/07/2020 |
CIGB |
Safety and efficacy of VAXIRA® in advanced NSCLC patients not progressing after first line chemotherapy. Phase III. |
01/10/2020 |
CIM |
Safety and efficacy of CIMAvax®-EGF in combination with tyrosine kinase inhibitors in patients with advanced stage Non-Small Cell Lung Cancer and EGFR mutations |
22/05/2021 |
CIM |
Rectal ozone therapy in high-risk symptomatic SARS-CoV-2 positive patients |
15/07/2021 |
CPN |
Rectal Ozone in the COVID-19 treatment |
05/06/2020 |
CPN |
Racotumomab-alum for recurrent platimun-sensitive epithelial ovarian cancer |
08/07/2015 |
CIM |
Racotumomab-alum cancer vaccine for solid tumors in pediatric patients |
15/12/2015 |
CIM |
Racotumomab vaccine- Lung Cancer- Adults-predictors of response - Exploratory |
09/07/2018 |
CIM |
Quimi-Hib® and Quimi-Hib(AlPO4) vaccines in an accelerated 6-10-14 weeks primary vaccination series |
2012-09-12 |
CIGB |
Quality of Life and safety of the nutritional supplement Deprexil® or Placebo in combination with cognitive stimulation treatment in patients with Mild Cognitive Impairment and Mild Alzheimer's Dementia. |
07/03/2024 |
CATALYSIS |
Quality of life and safety of CARMINAL® nutritional supplement in patients with mild or moderate ulcerative colitis |
29/02/2024 |
CATALYSIS |
Preventive use of CIMAvax-EGF in patients at high risk of lung cancer. PREVAX |
21/05/2021 |
CIM |
Policosanol-Atorvastatina for Ictus |
02/09/2013 |
CPN |
Policosanol in patients with pre-hypertension or with grade I hypertension |
30/06/2021 |
CPN |
Policosanol in patients with metabolic syndrome and ischaemic cardiopaty |
27/12/2016 |
CPN |
Policosanol + aspirin in post-stroke cognitive impairment |
30/06/2021 |
CPN |